Edition:
United States

People: Novo Nordisk A/S (NOVOb.CO)

NOVOb.CO on Copenhagen Stock Exchange

350.00DKK
10:59am EDT
Change (% chg)

kr.5.40 (+1.57%)
Prev Close
kr.344.60
Open
kr.345.50
Day's High
kr.350.00
Day's Low
kr.343.75
Volume
1,655,321
Avg. Vol
2,448,869
52-wk High
kr.350.00
52-wk Low
kr.265.15

Langa, Doug 

Mr. Doug Langa has been Executive Vice President, North America Operations at Novo Nordisk A/S since August 15, 2017. He has previously been Senior Vice President, Head of North America Operations, President of Novo Nordisk Inc. at Novo Nordisk A/S since March 1, 2017. He has previously been Senior Vice President for Market Access, Novo Nordisk Inc since 2016. He joined the company in 2011 as senior director, Managed Markets and in 2015 was appointed Corproate Vice President of Market Access in the US. He came from GlaxoSmithKline where he was senior director of Payer Marketing. Prior to GSK, Doug Langa spent the majority of his career at Johnson & Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing. He has over 25 years of experience in the pharmaceutical and medical device industry. He graduated from Widener University and earned MBA from Fordham University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --